![One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year](/i/c/7ca1462b-6110-0700-f4bf-1d1d81e81648.webp)
One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year
A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor
2023-11-13 09:15
![U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug](/i/c/e480f162-c083-a409-3a45-4bd7b8207705.webp)
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis
2023-11-01 07:29
![John Paulson’s $1 Billion Caribbean Empire Faces Betrayal](/i/c/d5cb71f2-50cf-420c-9779-28b4195bbc28.webp)
John Paulson’s $1 Billion Caribbean Empire Faces Betrayal
In the decade since hedge fund billionaire John Paulson took a grand gamble on Puerto Rico, he’s faced
2023-10-21 02:48
![Analysis-FTC settlement could shelter Amgen from US price cuts, taxes](/i/c/8b1cd212-79be-7b5a-88a3-a99f6822463c.webp)
Analysis-FTC settlement could shelter Amgen from US price cuts, taxes
By Deena Beasley The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics
2023-09-05 18:19
![Amgen settles with the FTC over $28 billion deal](/i/c/d726af51-bd1c-3706-f965-4d210f763f40.webp)
Amgen settles with the FTC over $28 billion deal
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September.
2023-09-02 00:17
![Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal](/i/c/df58f1b2-8f9f-8502-3bff-04a715845918.webp)
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
By Manas Mishra and David Shepardson (Reuters) -The U.S. Federal Trade Commission has allowed Amgen to go ahead with its
2023-09-01 23:00
![Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge](/i/c/bd02c252-c1bf-4f00-8925-905ed02b6358.webp)
Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge
Traders are almost 100% certain that Amgen Inc. will complete its $28 billion takeover of Horizon Therapeutics Plc
2023-08-29 01:45
![US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics](/i/c/09b2e467-2646-8f51-82f7-154d99ed5955.webp)
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics,
2023-08-26 23:51
![California, other states join FTC bid to block Amgen deal](/i/c/468bf420-afa5-8a90-3344-f14e18e20037.webp)
California, other states join FTC bid to block Amgen deal
The states of California, Minnesota and Wisconsin on Thursday joined a Federal Trade Commission lawsuit to stop Amgen's
2023-06-23 04:47
![Popular Hedge-Fund Trade Draws Fresh Scrutiny as Debt Battle Rages On](/i/c/c10e94f3-d6a5-1b19-44c8-8782f882ed57.webp)
Popular Hedge-Fund Trade Draws Fresh Scrutiny as Debt Battle Rages On
A highly leveraged bond trade that’s become popular with hedge funds is drawing fresh scrutiny three years after
2023-05-26 19:48
![FTC effort to stop Amgen's Horizon takeover faces uphill fight](/i/c/30a5b551-b952-65e5-c10f-1270d21be00e.webp)
FTC effort to stop Amgen's Horizon takeover faces uphill fight
By Diane Bartz WASHINGTON The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen
2023-05-18 23:19
![Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data](/i/c/93d0bb2d-df0a-2bf6-5f8d-050203e227d2.webp)
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20